Article
Lepidic, Papillary Components and EGFR Mutations are Frequent in Patients With Lung Adenocarcinoma Who are Over 75 Years Old.
Applied immunohistochemistry & molecular morphology : AIMM - 1 Oct 2019
Forest Fabien, Patoir Arnaud, Dal-Col Pierre, Da Cruz Vanessa, Camy Florian, Stachowicz Marie-Laure, Bayle-Bleuez Sophie, Fournel Pierre, Karpathiou Georgia, Péoc'h Michel
Abstract excerpt
Treatment for lung adenocarcinoma frequently diverges from standard treatment in older patients. Clinical, pathologic, and molecular characteristics of lung cancer in patients over 75 years old have not been fully described. The aim of our work was to describe the rate of EGFR, KRAS, BRAF, and HER2 mutations, and ALK rearrangement and pathologic characteristics in patients with lung adenocarcinoma over 75,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
